Nanobac Pharmaceuticals, Incorporated
NNBP
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.90K | 700.00 | 1.00K | 6.20K | 39.50K |
| Total Receivables | 1.90K | 1.80K | 1.70K | 200.00 | 700.00 |
| Inventory | 10.30K | 10.00K | 67.80K | 67.10K | 66.40K |
| Prepaid Expenses | 14.70K | 27.60K | 62.80K | 25.10K | 19.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 30.80K | 40.00K | 133.20K | 98.60K | 126.50K |
|
|
|||||
| Total Current Assets | 30.80K | 40.00K | 133.20K | 98.60K | 126.50K |
| Net Property, Plant & Equipment | 37.50K | 41.50K | 45.60K | 51.40K | 60.30K |
| Long-term Investments | 3.62M | 3.62M | 3.62M | 3.62M | 3.62M |
| Goodwill | 3.62M | 3.62M | 3.62M | 3.62M | 3.62M |
| Total Other Intangibles | 3.53M | 3.64M | 3.75M | 3.85M | 3.96M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.00K | 8.80K | 8.50K | 8.20K | 58.50K |
| Total Assets | 7.22M | 7.34M | 7.55M | 7.63M | 7.82M |
|
|
|||||
| Total Accounts Payable | 980.40K | 968.00K | 929.50K | 647.70K | 408.70K |
| Total Accrued Expenses | 767.00K | 1.78M | 892.20K | 849.20K | 524.00K |
| Short-term Debt | 4.12M | 3.92M | 3.63M | 3.31M | 5.37M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 876.10K | -- | 329.50K | 329.50K | -- |
| Total Other Current Liabilities | 876.10K | -- | 329.50K | 329.50K | -- |
| Total Current Liabilities | 6.75M | 6.66M | 5.78M | 5.14M | 6.30M |
|
|
|||||
| Total Current Liabilities | 6.75M | 6.66M | 5.78M | 5.14M | 6.30M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 4.12M | 3.92M | 3.63M | 3.31M | 5.37M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.84M | 2.84M | 2.84M | 2.84M | 2.84M |
| Total Liabilities | 9.58M | 9.50M | 8.62M | 7.97M | 9.14M |
|
|
|||||
| Common Stock & APIC | 26.67M | 25.68M | 25.89M | 25.89M | 21.06M |
| Retained Earnings | -28.93M | -27.76M | -26.93M | -26.21M | -22.35M |
| Treasury Stock & Other | -105.30K | -79.80K | -34.70K | -28.50K | -20.90K |
| Total Common Equity | -2.36M | -2.16M | -1.07M | -345.10K | -1.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.36M | -2.16M | -1.07M | -345.10K | -1.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.36M | -2.16M | -1.07M | -345.10K | -1.31M |
|
|
|||||